top of page
Profile
Join date: Jan 30, 2019
Posts
Feb 22, 2024 ∙ 2 min
GEN initiates Phase 1 study of the first-in-class investigational drug SUL-238
GEN initiates Phase 1 study of the first-in-class investigational drug SUL-238 Ankara, Türkiye - GEN, a leading specialty pharmaceutical...
243
0
Sep 3, 2023 ∙ 1 min
GEN is on the Fortune 500 Türkiye List!
As one of Türkiye's fastest-growing pharmaceutical companies, we are pleased to be included in the Fortune Turkey 500 list. We would like...
442
0
Aug 30, 2023 ∙ 1 min
GEN at CPHI Barcelona 2023!
GEN at CPHI Barcelona 2023! We will be at CPhI, the largest and most comprehensive pharmaceutical industry fair, held in Barcelona,...
36
0
GEN
Admin
More actions
bottom of page